Literature DB >> 17157489

Cross-talk between the endocytic pathway and the endoplasmic reticulum in cross-presentation by MHC class I molecules.

Ngozi Monu1, E Sergio Trombetta.   

Abstract

Cross-presentation of exogenous proteins on MHC class I complexes contributes to the priming CD8(+) T-cell responses. However, the mechanisms by which antigen-presenting cells transfer internalized proteins to the MHC class I loading pathway are not well understood. Endocytosed proteins often appear to require proteasomal processing and transport into the endoplasmic reticulum, but the intracellular routes involved in cross-presentation remain unclear. Understanding the molecular and cellular basis of cross-presentation will illuminate novel aspects of cell physiology and might lead to improved vaccine design.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157489     DOI: 10.1016/j.coi.2006.11.017

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  16 in total

1.  A proteasome-dependent, TAP-independent pathway for cross-presentation of phagocytosed antigen.

Authors:  Nawel Merzougui; Roland Kratzer; Loredana Saveanu; Peter van Endert
Journal:  EMBO Rep       Date:  2011-12-01       Impact factor: 8.807

2.  Dendritic cells continue to capture and present antigens after maturation in vivo.

Authors:  Scott B Drutman; E Sergio Trombetta
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

3.  Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells.

Authors:  Kuan-Yin Shen; Ying-Chyi Song; I-Hua Chen; Chih-Hsiang Leng; Hsin-Wei Chen; Hui-Ju Li; Pele Chong; Shih-Jen Liu
Journal:  J Immunol       Date:  2014-03-28       Impact factor: 5.422

4.  T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation.

Authors:  Sarah E Henrickson; Thorsten R Mempel; Irina B Mazo; Bai Liu; Maxim N Artyomov; Huan Zheng; Antonio Peixoto; Michael P Flynn; Balimkiz Senman; Tobias Junt; Hing C Wong; Arup K Chakraborty; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2008-01-20       Impact factor: 25.606

5.  HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway.

Authors:  Jodie P Goodridge; Ni Lee; Aura Burian; Chul-Woo Pyo; Scott S Tykodi; Edus H Warren; Cassian Yee; Stanley R Riddell; Daniel E Geraghty
Journal:  J Immunol       Date:  2013-07-12       Impact factor: 5.422

Review 6.  Providing ligands for MHC class I molecules.

Authors:  Peter van Endert
Journal:  Cell Mol Life Sci       Date:  2011-03-02       Impact factor: 9.261

7.  Prolonged antigen survival and cytosolic export in cross-presenting human gammadelta T cells.

Authors:  Simone Meuter; Matthias Eberl; Bernhard Moser
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-22       Impact factor: 11.205

8.  Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunity.

Authors:  Olivier Renaudet; Gargi Dasgupta; Ilham Bettahi; Alda Shi; Anthony B Nesburn; Pascal Dumy; Lbachir BenMohamed
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

9.  Target peptide sequence within infectious human immunodeficiency virus type 1 does not ensure envelope-specific T-helper cell reactivation: influences of cysteine protease and gamma interferon-induced thiol reductase activities.

Authors:  Robert Sealy; Wendy Chaka; Sherri Surman; Scott A Brown; Peter Cresswell; Julia L Hurwitz
Journal:  Clin Vaccine Immunol       Date:  2008-01-30

10.  Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response.

Authors:  P O Ilyinskii; A B Meriin; V L Gabai; O P Zhirnov; G Thoidis; A M Shneider
Journal:  Vaccine       Date:  2008-03-14       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.